Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria

A colistin-glycopeptide combination (CGC) has been shown in vitro to be synergistic against multidrug-resistant Gram-negative bacteria (MDR GNB), especially Acinetobacter baumannii, and to prevent further resistance. However, clinical data are lacking. We carried out a retrospective multicenter stud...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Petrosillo, Nicola, Giannella, Maddalena, Antonelli, Massimo, Antonini, Mario, Barsic, Bruno, Belancic, Laura, Inkaya A., Cagkan, De Pascale, Gennaro, Grilli, Elisabetta, Tumbarello, Mario, Akova, Murat
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2014
Soggetti:
Clinical Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910896/
https://ncbi.nlm.nih.gov/pubmed/24277037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00871-13
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi